Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

I-tech

60.50 SEK+0.17 %19.11, 17.27
Less than 1K followers

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+0.17 %
-1.94 %
-14.91 %
-3.97 %
+15.90 %
-6.92 %
+35.96 %
-13.07 %
+145.29 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Read more
Market cap
725.87M SEK
Turnover
1.03M SEK
Revenue
168.12M
EBIT %
24.41 %
P/E
21.61
Dividend yield-%
2.07 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4.2
2027

Annual report '26

6.5
2027

Interim report Q1'27

20.8
2027

Interim report Q2'27

Press release18.11.2026, 10.00

I-Tech's Nomination Committee appointed

I-tech
Press release03.11.2026, 16.41

Redeye: I-Tech: EU vote as expected

I-tech
Third party research03.11.2026, 14.39

I-tech: EU votes for non-renewal of Selektope - ABG

* EU member states back non-renewal of Selektope approval * Limited impact on near-term financials; EU ~4% of sales * Still positive on long-term prospects, but spill-over risk remains The decision and next steps I-Tech announced this afternoon that ...

I-tech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release03.11.2026, 14.10

EU Member States support non-renewal of Selektope approval; limited commercial impact expected

I-tech
Press release21.10.2026, 12.59

Redeye: I-Tech (Q3 Review): Navigating EU-BPR With a Strong Core

I-tech
Third party research19.10.2026, 08.30

I-tech: Order timing weighs but growth intact - ABG

* Q3 sales -9%, EBIT -20% vs. ABGSCe on timing and tech costs * We lower ‘26e-‘28e sales by 3% and EBIT adj. by 4%/6%/5% * EU vote outcome expected within a few weeks Q3 affected by order timing and technology costs Q3 sales were SEK 49m (-9% vs. ABGSCe...

I-tech
HCA Morgenbørs 16/10 - Fokus på I-tech i interview med CEO Markus Jönsson
Video16.10.2026, 10.20
by Jacob Frehr, Rasmus Køjborg

HCA Morgenbørs 16/10 - Fokus på I-tech i interview med CEO Markus Jönsson

Udsigt til en positiv åbning i Europa fra morgenstunden efter bedring i techaktierne. Fokus på Føroya Banki (opjustering af årets resultat). Gæst i studiet her til morgen er CEO Markus Jönsson fra I-Tech, der bl.a. vil tale om selskabets Q3-regnskab.

I-techCarlsbergDanske BankJyske BankRingkjøbing LandbobankNordeaRoyal UnibrewNovo NordiskNKT
Third party research16.10.2026, 08.44

I-tech: Solid growth but technology costs weigh - ABG

Sales -9% vs. ABGSCe, EBIT SEK 13m vs. ABGSCe 17m * Organic growth of 18%, strong gross margin 60% (57% LY) * We estimate opex includes ~SEK 2m for acquired and licensed tech Q3 results Sales came in at SEK 49m (-9% vs. ABGSCe 54m), +19% y-o-y (+18% ...

I-tech
Regulatory press release16.10.2026, 08.00

I-Tech AB (publ) (ticker: ITECH) publish the interim report Q3 for 2026

I-tech
Press release15.10.2026, 16.36

Redeye: I-Tech: Signs Aquaculture license agreement

I-tech
Press release15.10.2026, 09.30

I-Tech enters exclusive aquaculture licence agreement with Titanium Technology

I-tech
Third party research13.10.2026, 07.09

I-tech: Expecting broad-based growth - ABG

* Q3e: +29% organic growth, EBIT SEK 17m (11m) * '27e-'28e adj. EBIT raised by 6-8% on FX * EU vote ahead; '27e/'28e EV/EBIT of 6x/4x, ~60-80% below peers Q3 expectations We estimate Q3 sales of SEK 54m, +31% y-o-y (+29% org., +2% FX). We expect growth...

I-tech
Press release24.08.2026, 12.11

Redeye: I-Tech (Q2 Review): Strong execution and momentum

I-tech
Third party research24.08.2026, 08.22

I-tech: Beyond a single molecule - ABG

* Q2 organic growth of +91% marks a record quarter * We raise '26e-'28e sales by 7% and EBIT by 23%, 13% & 9% * New aquaculture market entered; EU vote still pending Record quarter, easy comps aside I-Tech delivered very strong Q2 results, with 91% organic...

I-tech
Third party research21.08.2026, 09.22

I-tech: Strongest quarter on record - ABG

Sales +21% vs. ABGSCe, EBIT SEK 21m vs. ABGSCe 13m Easy comps, but +91% organic growth still very strong Gross margin held at 59%; raw-material pressure mitigated so far Q2 results I-tech reported very strong Q2 numbers. Sales came in at SEK 59m (+21...

I-tech
Regulatory press release21.08.2026, 08.00

I-Tech AB (publ) (ticker: ITECH) publish the Q2 half-year report for 2026

I-tech
Press release19.08.2026, 10.00

I-Tech acquires rights to biologically derived antifouling technology to expand sustainable solutions portfolio

I-tech
Third party research16.07.2026, 11.59

I-tech: Smooth sailing into easy comps - ABG

* Q2e: +58% organic growth, EBIT SEK 13m (5m) * Easy comps: customer with financial constraints not in Q2'25 base * Trading at '26e-'28e EV/EBIT 11x-5x, ~40-60% below peers Q2 expectations We estimate Q2 sales of SEK 48m, +53% y-o-y (+58% organic, -5...

I-tech
Regulatory press release21.05.2026, 17.42

Report from the Annual General Meeting 2026 of i-tech AB (publ)

I-tech
Press release20.05.2026, 14.00

Change to the Board nomination proposal ahead of I‑Tech AB’s Annual General Meeting

I-tech